MY ACCOUNT | NEWSLETTER |

Otto Partners with Industry Leaders to Provide Free Access to AI Scribe


Otto, the veterinary technology company trusted by more than 5,000 clinics, today announced that Hill’s Pet Nutrition and The Veterinary Cooperative (TVC) are partnering with Otto to provide clinics with access free of charge to Otto AI Scribe, expanding the availability of veterinary-specific documentation tools to Hill’s Connect clinic partners and to TVC member clinics.

This collaboration marks a major step forward in giving veterinary teams access to the industry’s most accurate and easy-to-use AI scribe tool, one designed specifically for the realities of veterinary practice, not adapted from another industry.

Built for Clinics. Backed by Industry Leaders.

Otto’s AI Scribe generates accurate SOAP-formatted notes, helping ensure client communications, treatment plans, and education don’t fall through the cracks. Clinic team members are saving an average of 30 hours per month when fully utilizing Scribe.

“Complete and connected clinic records are essential for a pet’s care,” said Dr. Chelsie Estey, Chief Veterinary Officer of Hill’s Pet Nutrition U.S. “Otto AI Scribe ensures education and recommendations, including nutrition, are captured, improving adherence and continuity of care.”

“Otto separated itself by bringing real scale, proven performance, and a strong level of veterinary sector focus. They have what it takes to bring real scale to the AI scribe market,” said Nick McCart, President of TVC. “In a space full of new entrants, Otto has already demonstrated the needed maturity and reliability our member hospitals really depend on.”

A Shared Vision for Smarter, More Connected Care

“We’re thrilled that industry partners are choosing Otto AI Scribe,” said Zeynep Young, CEO of Otto. “They share our belief that every clinic—large or small—deserves access to technology that makes work easier, care better, and clients more connected. This collaboration is a testament to what can happen when innovation meets true industry partnership.”

Otto AI Scribe is already used by thousands of vets across North America, helping doctors complete records faster, improve compliance, and reduce administrative stress. This new partnership dramatically expands access, giving thousands more veterinary teams the ability to capture what matters most—accurately, affordably, and automatically. Any TVC clinic can sign up for free by going to www.otto.vet/signup and selecting “TVC” from the referral field dropdown, or clinics can learn more about Otto’s Scribe capabilities at www.otto.vet/scribe-tvc/.

Why Industry Leaders Chose Otto AI Scribe

  • Veterinary-trained AI captures what matters—clinical signs, treatment plans, and SOAP structure—not small talk.
  • Custom templates and flexible formats to match each doctor’s preferences.
  • Multi-pet support without confusion or note merging.
  • Deepest integrations in the industry, including automatic task generation and follow-up assignment, when used with Otto Flow.
  • Notes 1 minute after the exam. Otto AI quickly turns conversation into accurate, editable notes.
  • Trusted by 5,000+ clinics and built by a team that understands veterinary workflow firsthand.

About Otto

Otto is a veterinary technology company focused on helping over 5,000 clinics grow and thrive while protecting team balance. Designed by people who know the realities of veterinary practice, Otto delivers automated client communications, digital forms, direct booking, payment tools, AI scribe and workflow solutions that integrate seamlessly with leading PIMS. Unlike many platforms, Otto is 100% veterinary-focused, comes with all capabilities available out-of-the-box, and supported by a team of vet professionals who have lived the day-to-day realities of the industry. From small animal clinics to specialty and ER hospitals, Otto helps veterinary teams fill their schedule, streamline operations, reduce burnout, and focus on high-quality care.


Source:
www.otto.vet

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

How a Better Bile Acid Could Keep C. diff at Bay

Like0
Dislike0

Sleepypod Launches Clickit Range, a Car Safety Harness Designed and Tested to Protect a Broader Spectrum of Canine Body Types

Like0
Dislike0

Rescue therapy with doxorubicin-based chemotherapy for relapsing or refractory feline lymphoma: a retrospective study of 23 cases

Like0
Dislike0

Treatment of demodicosis in dogs: 2011 clinical practice guidelines

Like0
Dislike0

Antibiotics in Canadian poultry productions and anticipated alternatives

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top